The Tennessee Department of Health will conduct regional workshops across the state in October and November, providing residents and healthcare professionals opportunities to suggest ways to improve population health. The Nashville session is scheduled for:
Oct. 21 - 9:00 a.m. to 1:00 p.m., Lentz Public Health Center, Nashville
In addition, ETSU will host a population health improvement feedback session starting 10 a.m. Nov. 9 in the Natural History Museum; this session is also open to the general public. Information from the meetings will be assessed to help TDH develop a stronger state health plan for 2017 and beyond.
"The Tennessee Vital Signs Workshops will give people in Tennessee voice on how population health should be defined and measured, and to have conversations with others about population health needs and concerns," said TDH Commissioner John Dreyzehner, MD, MPH. "While all of us want healthcare to be there when we need it, what we really want is simply health itself, and these workshops will help us better understand what that looks like from a variety of viewpoints."
"From our perspective, the state health plan is a living document that needs the thoughts and voices of many stakeholders to ensure it continually impacts health where we live, labor, learn, play and pray," said TDH Health Planning Director Jeff Ockerman. "The workshops will provide a great opportunity for residents to have their voices heard and to help shape the state health plan in a way that positively affects all Tennesseans."
Those who wish to participate in the meetings may send an email to firstname.lastname@example.org or call 615-741-1739. Additional information is also available online at: Health Planning Announcements
A Polygenic Risk Score -- a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients -- has been found not to be a useful predictive biomarker for disease risk, according to a Vanderbilt study published in the Journal of the American Medical Association.
Most Tennessee infants exposed to hepatitis C at birth are not later tested to see if they acquired the virus, according to a study by researchers at Monroe Carell Jr. Children's Hospital at Vanderbilt and the Vanderbilt Center for Child Health Policy.
With the Tennessee General Assembly back in full swing, the state's major healthcare associations outline 2020 priorities.
From transplants to trials, Nashville hospitals are leading the way in cardiac care.
Technology has changed every aspect of our lives. In fact, I had a healthy laugh a few weeks ago when I showed my children an old rotary phone and, get this, they did not know what it was.
In late January, a group of more than 25 organizations from across Tennessee announced their support for legislation that seeks to prevent the next generation of nicotine addicts in the state.
TriStar Summit cardiologist Kristen Kerr is passionate about education, improving outcomes in women's heart health.
Following successful preclinical trials and FDA funding, Cumberland Pharmaceuticals is preparing to launch a new Phase II trial of ifetroban to treat cardiomyopathy in Duchenne Muscular Dystrophy patients.
Endocrine Society Chief Professional & Clinical Affairs Officer Robert Lash, MD, discusses the field, annual meeting, road shows and more.